← Back to Patent Explorer
US5298612A Expired / Lapsed US ⏱️ 0.0 years remaining

Endonucleases

Assignee: Gene Shears Pty Ltd
•
Filing: 1991-06-19
•
Granted: 1994-03-29
•
Expires: 2011-06-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention provides catalytic molecules capable of cleaving target nucleotide sequences. More specifically, the invention provides an endonuclease having nucleotide sequences which are of sufficient length to allow hybridisation to a target nucleotide sequence desired to be cleaved. The endonuclease contains a catalytic region comprising ribonucleotides and/or deoxyribonucleotides, or derivatives thereof which act to cleave a phosphodiester bond of the substrate nucleotide sequence. The catalytic region comprises nucleotides or derivatives thereof which are linked by linking groups which may comprise ribonucleotides, deoxyribonucleotides or combinations thereof. The endonucleases of the invention are useful in the cleavage of target RNAs associated with disease in humans and animals and in the inactivation of RNA transcripts in eukaryotic and prokaryotic cells, as well as the cleavage of RNA transcripts in-vitro.

Inventors

  • 👤 Philip A. Jennings
  • 👤 Masine J. McCall
  • 👤 Philip Hendry

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 18:11
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; A; A61; A61P; A61P17/00; A61P31/00; A61P31/12; C12N9/00; C12N9/14; C12N9/16; C12N9/22; A61K; A61K38/00; C12N2310/00; C12N2310/10; C12N2310/11; C12N2310/111; C12N2310/12; C12N2310/121; C12N2310/30; C12N2310/32; C12N2310/322

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 133 words
A compound having the structure: ##STR2## wherein each X represents a ribonucleotide or a deoxyribonucleotide which is the same or different and may be modified in its phosphate; wherein (X) n and (X) n , represent oligonucleotides in which n and n' are integers which define the number of nucleotides in the oligonucleotides, such oligonucleotides having predetermined sequences sufficiently complementary to a predefined RNA target sequence to be cleaved to allow hybridization to the RNA target sequence; wherein N may be adenine, guanine, cytosine or uracil; wherein each solid line represents a chemical linkage providing covalent bonds between the nucleotides located on either side thereof; wherein m represents an integer from 2 to 20; and wherein none of the nucleotides (X) m are Watson-Crick base paired to any other nucleotide within the compound.
Claim 2
Dependent Claim 133 words
A compound having the structure: ##STR2## wherein each X represents a ribonucleotide or a deoxyribonucleotide which is the same or different and may be modified in its phosphate; wherein (X) n and (X) n , represent oligonucleotides in which n and n' are integers which define the number of nucleotides in the oligonucleotides, such oligonucleotides having predetermined sequences sufficiently complementary to a predefined RNA target sequence to be cleaved to allow hybridization to the RNA target sequence; wherein N may be adenine, guanine, cytosine or uracil; wherein each solid line represents a chemical linkage providing covalent bonds between the nucleotides located on either side thereof; wherein m represents an integer from 2 to 20; and wherein none of the nucleotides (X) m are Watson-Crick base paired to any other nucleotide within the compound.
Claim 3
Dependent Claim 12 words
A compound of claim 1, wherein each of X represents a ribonucleotide.
Claim 4
Dependent Claim 11 words
A compound of claim 1, wherein each X represents a deoxyribonucleotide.
Claim 5
Dependent Claim 17 words
A compound of claim 1, 2, or 3 wherein m is an integer from 2 to 6.

References Cited (Backward Citations)

US4511713A Cited
US5023243A Cited
US4987071A Cited
WO1989005852A1 Cited
US5149796A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-03-28 1997-09-27 1998-03-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-03-28 2001-09-27 2002-03-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-03-28 2005-09-27 2006-03-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag